Multimodal Analgesia in Major Abdominal Pediatric Cancer Surgeries
Pediatric Cancer, Pain, Postoperative

About this trial
This is an interventional prevention trial for Pediatric Cancer
Eligibility Criteria
Inclusion Criteria:
- were ASA I or II patients.
- Aged between 5 and 12 years.
- Both sexes.
- Scheduled for major abdominal surgery with a midline incision.
Exclusion Criteria:
- included history of mental retardation or delayed development that may interfere with pain intensity assessment,
- Known or suspected allergy to any administered drugs.
- Active renal (creatinine clearance <50).
- Hepatic (liver enzymes more than 10 folds).
- Respiratory (SPO2 <92% on room air).
- Cardiac disease (ejection fraction < 50%).
Sites / Locations
- Department of Anesthesia and Pain medicine.National Cancer Institute
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Drug: Morphine
Procedure/surgery:Caudal levobupivacaine
Drug: Paracetamol and ketamine
Morphine Group C (n=30) was the control group who received IV morphine in a dose of 0.1 mg/kg after induction of anesthesia
In Caudal Group (n=30), patients were placed in the lateral position and received caudal epidural block after induction of anesthesia with levobupivacaine 0.125% , 1.1 ml/kg and morphine 0.02 mg/kg with maximum 20ml.
The patients of Multimodal Group (n=30) received paracetamol infusion 10 mg/kg over 10 minutes and ketamine 0.5 mg/kg IV bolus followed by ketorolac 1 mg/kg infusion over 10 minutes.